Treatment of menstrual migraine: utility of control of related mood disturbances

References

• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-96
   PubMed Web of Science ®Google Scholar
• Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 2012;13:361-78
   PubMed Web of Science ®Google Scholar
• Sacco S, Ripa P, Grassi D, et al. Peripheral vascular dysfunction in migraine: a review. J Headache Pain 2013;14:80
   PubMed Web of Science ®Google Scholar
• Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914
   PubMed Web of Science ®Google Scholar
• Martelletti P, Birbeck GL, Katsarava Z, et al. The global burden of disease survey 2010, lifting the burden and thinking outside-the-box on headache disorders. J Headache Pain 2013;14:13
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Victor TW, Hu X, et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache 2010;50:528-38
   PubMed Web of Science ®Google Scholar
• Pinkerman B, Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia 2010;30:1187-94
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004;63:351-3
   PubMed Web of Science ®Google Scholar
• Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain 2011;12(2):115-25
   PubMed Web of Science ®Google Scholar
• Allais G, Castagnoli Gabellari I, Burzio C, et al. Premenstrual syndrome and migraine. Neurol Sci 2012;33(Suppl 1):S111-15
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. American Psychiatric Association; Arlington: 2013
   Google Scholar
• Fragoso YD, Guidoni AC, de Castro LB. Characterization of headaches in the premenstrual tension syndrome. Arq Neuropsiquiatr 2009;67:40-2
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Neri I, Martignoni E, et al. The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993;13:422-5
   PubMed Web of Science ®Google Scholar
• Martin VT, Wernke S, Mandell K, et al. Symptoms of premenstrual syndrome and their association with migraine headache. Headache 2006;46(1):125-37
   PubMed Web of Science ®Google Scholar
• Sundić A, Zidverc-Trajković J, Vujović S, Sternić N. Perimenstrual headache: migraine without aura or premenstrual syndrome symptom? Vojnosanit Pregl 2010;67(12):969-76
   PubMed Web of Science ®Google Scholar
• Keenan PA, Lindamer LA. Non-migraine headache across the menstrual cycle in women with and without premenstrual syndrome. Cephalalgia 1992;12(6):356-9. discussion 339
   PubMed Web of Science ®Google Scholar
• Payne JL, Roy PS, Murphy-Eberenz K, et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 2007;99:221-9
   PubMed Web of Science ®Google Scholar
• Yonkers KA. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997;58(Suppl 15):19-25
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9
   PubMed Web of Science ®Google Scholar
• Stewart WF, Wood C, Reed ML, et al. AMPP Advisory Group. Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008;28:1170-8
   PubMed Web of Science ®Google Scholar
• Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 2012;13:177-89
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Self-reported menstrual migraine in the general population. J Headache Pain 2010;11:87-92
   PubMed Web of Science ®Google Scholar
• Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991;134:1111-20
   PubMed Web of Science ®Google Scholar
• Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 1994;44(Suppl 4):S24-39
   Google Scholar
• Kaplan I, Sadock J. Comprehensive textbook of psychiatry. Volumes 1 & 2 5th edition. Williams & Wilkins Co; Baltimore, MD, US: 1989. p. XXVI-2158
   Google Scholar
• Yavuz BG, Aydinlar EI, Dikmen PY, Incesu C. Association between somatic amplification, anxiety, depression, stress and migraine. J Headache Pain 2013;14:53
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Costa EA, da Silva AA. Jr, et al. Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples. J Headache Pain 2012;13:551-5
   PubMed Web of Science ®Google Scholar
• Rausa M, Cevoli S, Sancisi E, et al. Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center. J Headache Pain 2013;14:22
   PubMed Web of Science ®Google Scholar
• Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2004;25:165-78
   Web of Science ®Google Scholar
• Juang KD, Wang SJ, Fuh JL, et al. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000;40:818-23
   PubMed Web of Science ®Google Scholar
• Breslau N, Schultz LR, Stewart WF, et al. Headache and major depression. Is the association specific to migraine? Neurology 2000;54:308-13
   PubMed Web of Science ®Google Scholar
• Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355-65
   PubMed Web of Science ®Google Scholar
• Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971;21:853-9
   PubMed Web of Science ®Google Scholar
• MacGregor EA, Frith A, Ellis J, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154-8
   PubMed Web of Science ®Google Scholar
• Kvisvik EV, Stovner LJ, Helde G, et al. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011;12:443-51
   PubMed Web of Science ®Google Scholar
• Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil Steril 1997;67:390-3
   PubMed Web of Science ®Google Scholar
• Davies PT, Eccles N, Steiner TJ, et al. Plasma estrogen, progesterone and sex hormone binding globulin levels in the pathogenesis of migraine. Cephalalgia 1989;9:143
   Google Scholar
• Karli N, Baykan B, Ertaş M, et al. Turkish Headache Prevalence Study Group, Onal AE. Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain 2012;13:557-65
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Poitras JR, et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003;160:1519-22
   PubMed Web of Science ®Google Scholar
• Dalton K. Menstruation and acute psychiatric illnesses. BMJ 1959;34:148-9
   Google Scholar
• Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I. Headache 2006;46:3-23
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Granella F, Prudenzano MP, et al. Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012;13(Suppl 2):S31-70
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Birk S, Kasch H, et al. Danish Headache Society. Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition. J Headache Pain 2012;13(Suppl 1):S1-29
   Google Scholar
• Evers S, Afra J, Frese A, et al. European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 2009;16:968-81
   PubMed Web of Science ®Google Scholar
• Casolla B, Lionetto L, Candela S, et al. Treatment of perimenstrual migraine with triptans: an update. Curr Pain Headache Rep 2012;16:445-51
   PubMed Web of Science ®Google Scholar
• Ferrari A, Tiraferri I, Neri L, Sternieri E. Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain 2011;12:5-12
   PubMed Web of Science ®Google Scholar
• Mannix L, Files J. The use of triptans in the management of mestrual migraine. CNS Drugs 2005;19:951-72
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Davenport W, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 2008;70:1555-63
   PubMed Web of Science ®Google Scholar
• Yang LP. Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine. Drugs 2013;73:1339-55
   PubMed Web of Science ®Google Scholar
• Allais G, Rolando S, Schiapparelli P, et al. Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study. Neurol Sci 2013;34(Suppl 1):S179-81
   Web of Science ®Google Scholar
• Bigal M, Sheftell F, Tepper S, et al. A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 2008;48:1286-93
   PubMed Web of Science ®Google Scholar
• Smith TR, Sunshine A, Stark SR, et al. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 2005;45:983-91
   PubMed Web of Science ®Google Scholar
• Durham PL, Vause CV, Derosier F, et al. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea. Headache 2010;50(5):844-51
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Prevention and treatment of menstrual migraine. Drugs 2010;70:1799-818
   PubMed Web of Science ®Google Scholar
• Macgregor EA. Menstrual migraine: therapeutic approaches. Ther Adv Neurol Disord 2009;2:327-36
   PubMedGoogle Scholar
• Silberstein SD, Hutchinson SL. Diagnosis and treatment of menstrual migraine patient. Headache 2008;48(Suppl 3):S115-23
   Google Scholar
• MacGregor EA, Frith A, Ellis J, Aspinall L. Predicting menstrual migraine with a home-use fertility monitor. Neurology 2005;64:561-3
   PubMed Web of Science ®Google Scholar
• Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 2011;12:593-601
   PubMed Web of Science ®Google Scholar
• Silberstein S, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1337-45
   PubMed Web of Science ®Google Scholar
• Hu Y, Guan X, Fan L, Jin L. Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain 2013;14:7
   PubMed Web of Science ®Google Scholar
• Negro A, Lionetto L, Casolla B, et al. Pharmacokinetic evaluation of frovatriptan. Expert Opin Drug Metab Toxicol 2011;7:1449-58
   PubMed Web of Science ®Google Scholar
• Calhoun AH. Menstrual migraine: update on pathophysiology and approach to therapy and management. Curr Treat Options Neurol 2012;14:1-14
   PubMed Web of Science ®Google Scholar
• Wood C, Jakubowicz D. The treatment of premenstrual symptoms with mefenamic acid. Br J Obstet Gynaecol 1980;87:627-30
   PubMedGoogle Scholar
• Mira M, McNeil D, Fraser IS, et al. Mefenamic acid in the treatment of premenstrual syndrome. Obstet Gynecol 1986;68:395-8
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Fioroni L, Sances G, et al. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. Gynecol Obstet Invest 1989;28:205-8
   PubMed Web of Science ®Google Scholar
• Bach PH, Berndt WO, Delzell E, et al. A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine. Ren Fail 1998;20:749-62
   PubMed Web of Science ®Google Scholar
• Psychotropic Writing Group. Therapeutic guidelines: psychotropic. Version 6 Updated March 2010 [eTG complete CD-ROM] Therapeutic Guidelines Ltd; Melbourne: 2008
   Google Scholar
• Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997;37:693-703
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Viale CI, Kapczinski F. Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol. Can J Psychiatry 2001;46:454-5
   PubMed Web of Science ®Google Scholar
• Ogawa N, Ueki H. Secondary mania caused by caffeine. Gen Hosp Psychiatry 2003;25:138-9
   PubMed Web of Science ®Google Scholar
• Shah NR, Jones JB, Aperi J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 2008;111(5):1175-82
   PubMed Web of Science ®Google Scholar
• Peres MF, Mercante JP, Tanuri FC, et al. Chronic migraine prevention with topiramate. J Headache Pain 2006;7(4):185-7
   PubMedGoogle Scholar
• Phabphal K, Udomratn P. Topiramate-induced depression in cases using topiramate for migraine prophylaxis. Cephalalgia 2010;30(6):747-9
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association: practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(Suppl 12):1-36
   Google Scholar
• Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;8:177-81
   Google Scholar
• De Souza MC, Walker AF, Robinson PA, et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 2000;9:131-9
   PubMedGoogle Scholar
• Fathizadeh N, Ebrahimi E, Valiani M, et al. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res 2010;15(Suppl 1):401-5
   PubMedGoogle Scholar
• Lopez LM, Kaptein AA, Helmerhorst FM Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2012;2:CD006586
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Kuehl TJ, Ortiz M, et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002;186:1142-9
   PubMed Web of Science ®Google Scholar
• Ozgoli G, Selselei EA, Mojab F, et al. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complem Med 2009;15:845-51
   PubMed Web of Science ®Google Scholar
• Mangone CA, Herskovits E. Extrapyramidal and depressive side reactions with flunarizine and cinarizine. J Neurol Neurosurg Psychiatry 1989;52:288-9
   PubMed Web of Science ®Google Scholar
• Capellà D, Laporte JR, Castel JM, et al. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine. BMJ 1988;297:722-3
   PubMedGoogle Scholar
• Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986;255:357-60
   PubMed Web of Science ®Google Scholar
• Rockett FC, Perla AD, Perry ID, Chaves ML. Cardiovascular disease risk in women with migraine. J Headache Pain 2013;14:75
   PubMed Web of Science ®Google Scholar
• Thiessen BQ, Wallace SM, Blackburn JL, et al. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med 1990;150:2286-90
   PubMedGoogle Scholar
• Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005;6(6):429-40
   PubMedGoogle Scholar
• Vetvik KG, Macgregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: A population-based study. Cephalalgia 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar